Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Paige Meizlik"'
Autor:
Anne Hammer, Beulah Ji, David A Roth, David D'Cruz, Paige Meizlik, Gina Eriksson, Yulia Green
Publikováno v:
Lupus Science and Medicine, Vol 10, Iss 1 (2023)
Objective Assess the safety and efficacy of belimumab in older adults with SLE.Methods This post hoc integrated analysis (GSK Study 116559) included safety data from six randomised, placebo-controlled belimumab trials (BLISS-76, BLISS-52, BLISS-SC, N
Externí odkaz:
https://doaj.org/article/238a809959434cd0bbf78b08d243c9e0
Autor:
Jeanne M Pimenta, Jeffery L Painter, Kim Gemzoe, Roger Abramino Levy, Marcy Powell, Paige Meizlik, Gregory Powell
Publikováno v:
JMIR Formative Research, Vol 6, Iss 5, p e30573 (2022)
BackgroundEnrollment in pregnancy registries is challenging despite substantial awareness-raising activities, generally resulting in low recruitment owing to limited safety data. Understanding patient and physician awareness of and attitudes toward p
Externí odkaz:
https://doaj.org/article/045323fe431f49e58366ea53556595fd
Autor:
Damon Bass, Regina Kurrasch, Yin Su, Jie Zheng, Yang Li, Guochun Wang, Fengchun Zhang, David A Roth, Jieruo Gu, Jenny Lowe, Myron Chu, Paula Curtis, Kathleen DeRose, Paige Meizlik, Mingjun Wang, Xingfu Li
Publikováno v:
RMD Open, Vol 8, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/3bb0c03d67a54994b11d4268d0320b01
Autor:
Damon Bass, Regina Kurrasch, Sang-Cheol Bae, Beulah Ji, David A Roth, Jenny Lowe, Myron Chu, Paula Curtis, Kathleen DeRose, Paige Meizlik
Publikováno v:
RMD Open, Vol 7, Iss 2 (2021)
Objectives To evaluate the long-term safety and efficacy of belimumab in patients with systemic lupus erythematosus (SLE) from Japan and South Korea.Methods In this phase III, open-label continuation study (BEL114333; NCT01597622), eligible completer
Externí odkaz:
https://doaj.org/article/38e1bf50528c441588e79d0ea8c81c17
Autor:
Daniel J, Wallace, Tatsuya, Atsumi, Mark, Daniels, Anne, Hammer, Paige, Meizlik, Holly, Quasny, Andreas, Schwarting, Fengchun, Zhang, David A, Roth
Publikováno v:
Lupus. 31:1649-1659
ObjectivesSystemic lupus erythematosus (SLE) is a chronic, autoimmune disease that affects multiple organ systems. Belimumab, a targeted human monoclonal antibody, binds to and inhibits soluble B-lymphocyte stimulator. The safety and efficacy of beli
Autor:
Patricia Juliao, Keele Wurst, Jeanne M. Pimenta, Kim Gemzoe, Helain Landy, M. Anthony Moody, Hugh Tilson, Deborah Covington, Tammy Moore, Rebecca Marino, Jennifer Gilbride, Andrew Liu, Paige Meizlik, Michelle Petri
Publikováno v:
Birth defects researchREFERENCES.
Belimumab is approved for active, autoantibody-positive systemic lupus erythematosus (SLE) and lupus nephritis, but limited data exist regarding its use in pregnancy. The Belimumab Pregnancy Registry (BPR, GSK Study BEL114256; NCT01532310) was create
Autor:
David D'Cruz, Gina Eriksson, Yulia Green, Anne Hammer, Beulah Ji, Paige Meizlik, David A Roth
Publikováno v:
Lupus Science & Medicine. 10:e000830
ObjectiveAssess the safety and efficacy of belimumab in older adults with SLE.MethodsThis post hoc integrated analysis (GSK Study 116559) included safety data from six randomised, placebo-controlled belimumab trials (BLISS-76, BLISS-52, BLISS-SC, Nor
Autor:
Jie Zheng, Jieruo Gu, Yin Su, Yang Li, Xingfu Li, Cui Xiong, Hua Cao, Holly Quasny, Myron Chu, Paula Curtis, Kathleen DeRose, Regina Kurrasch, Paige Meizlik, David A Roth, Fengchun Zhang
Publikováno v:
Modern rheumatology.
Objectives To assess belimumab efficacy in patients from North East Asia (NEA) with systemic lupus erythematosus (SLE) in baseline demographic/disease characteristic subgroups. Methods This analysis of patient subgroups from BLISS-NEA (GSK Study 1137
Autor:
Michelle Petri, Helain Landy, Megan E B Clowse, Kim Gemzoe, Munther Khamashta, Milena Kurtinecz, Roger A Levy, Andrew Liu, Rebecca Marino, Paige Meizlik, Jeanne M Pimenta, Kelsey Sumner, Hugh Tilson, Mary Beth Connolly, Keele Wurst, Julia Harris, Holly Quasny, Patricia Juliao, David A Roth
Publikováno v:
Annals of the rheumatic diseases.
ObjectiveDescribe available data on birth defects and pregnancy loss in women with systemic lupus erythematosus (SLE) exposed to belimumab.MethodsData collected from belimumab clinical trials, the Belimumab Pregnancy Registry (BPR), and postmarketing
Autor:
Paula S. Curtis, Jenny Lowe, Paige Meizlik, Damon Bass, Myron Chu, Sang Cheol Bae, Kathleen DeRose, Beulah Ji, Yoshiya Tanaka, David M. Roth, Regina Kurrasch
Publikováno v:
RMD Open
RMD Open, Vol 7, Iss 2 (2021)
RMD Open, Vol 7, Iss 2 (2021)
ObjectivesTo evaluate the long-term safety and efficacy of belimumab in patients with systemic lupus erythematosus (SLE) from Japan and South Korea.MethodsIn this phase III, open-label continuation study (BEL114333; NCT01597622), eligible completers